Jerrold Duane Dotson is VP, CFO of VistaGen Therapeutics, Inc.. Currently has a direct ownership of 3,671 shares of VTGN, which is worth approximately $12,077. The most recent transaction as insider was on Jun 30, 2023, when has been sold 167 shares (Common Stock) at a price of $1.59 per share, resulting in proceeds of $265. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.67K
0% 3M change
0% 12M change
Total Value Held $12,077

JERROLD DUANE DOTSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2023
BUY
Grant, award, or other acquisition
$265 $1.59 p/Share
167 Added 4.35%
3,671 Common Stock
Dec 30 2022
BUY
Grant, award, or other acquisition
$450 $0.09 p/Share
5,000 Added 4.54%
105,111 Common Stock
Jul 30 2022
BUY
Grant, award, or other acquisition
$3,750 $0.75 p/Share
5,000 Added 4.76%
100,111 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$18,750 $1.0 p/Share
18,750 Added 16.55%
94,571 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$5,934 $1.66 p/Share
3,575 Added 4.5%
75,821 Common Stock
Sep 07 2021
SELL
Open market or private sale
$93,600 $3.12 p/Share
30,000 Reduced 29.19%
72,786 Common Stock
Jun 30 2021
BUY
Exercise of conversion of derivative security
$87,050 $0.97 p/Share
89,742 Added 46.61%
102,786 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$5,936 $1.95 p/Share
3,044 Added 18.92%
13,044 Common Stock
Dec 31 2020
BUY
Grant, award, or other acquisition
$2,250 $0.45 p/Share
5,000 Added 33.33%
10,000 Common Stock
JDD

Jerrold Duane Dotson

VP, CFO
South San Francisco, CA

Track Institutional and Insider Activities on VTGN

Follow VistaGen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTGN shares.

Notify only if

Insider Trading

Get notified when an Vista Gen Therapeutics, Inc. insider buys or sells VTGN shares.

Notify only if

News

Receive news related to VistaGen Therapeutics, Inc.

Track Activities on VTGN